Stents Drug Eluting

May 1, 2017 — The U.S. Food and Drug Administration (FDA) approved Medtronic’s Resolute Onyx Drug-eluting Stent (DES).

This video, provided by Medtronic, demonstrates the Resolute Onyx coronary stent. It was cleared by the FDA and launched into the U.S. market May 1, 2017.

Biosensors International Group Ltd. announced in February enrollment of the first patient in LEADERS FREE II, its new BioFreedom Pivotal Study. The study will be conducted under an Investigational...

March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc. first-in-class Cobra PzF NanoCoated Coronary Stent System.